Interested in Tool Compounds to Explore Neurodegenrative Conditions (Avilex Pharma)

il y a 2 ans

Avilex Pharma



Recherche partenariat

Recherche partenaire principal

Avilex Pharma is specialized in designing and developing peptide based inhibitors targeting PDZ domain proteins, in particular PSD-95, which is a post-synaptic density protein involved in neurodegenerative disorders. Avilex Pharma offers the provision of novel tool compounds to explore and evaluate in models of such conditions. Thus, Avilex Pharma – as a chemical synthesis expert – seeks biological partners in the neuroscience area to examine novel neuroprotective drug-like compounds in relevant in vitro and in vivo models of neurodegenerative diseases, thereby collaborating to gain fundamental mechanistic insights into the complex pathology of synaptic signalling.

 Transfert de technologie
 Innovation & Recherche
 Biotechnologie médicale

Appels recommandés pour cette idée
Si vous connaissez un appel qui peut correspondre à cette idée

Recommander un appel